CIAMPORCERO, ERIC STEFANO
CIAMPORCERO, ERIC STEFANO
SCIENZE CLINICHE E BIOLOGICHE
AS601245, an anti-inflammatory JNK inhibitor, and clofibrate have a synergistic effect in inducing cell responses and in affecting the gene expression profile, in CaCo-2 colon cancer cells.
2012-01-01 Angelo Cerbone; Cristina Toaldo; Stefania Pizzimenti; Piergiorgio Pettazzoni; Chiara Dianzani; Rosalba Minelli; Eric Ciamporcero; Guglielmo Roma; Mario Umberto Dianzani; Roberto Canaparo; Carlo Ferretti; and Giuseppina Barrera
Cancer Cells Haploinsufficient for ATM Are Sensitized to PARP Inhibitors by MET Inhibition
2022-01-01 D'Ambrosio, Concetta; Erriquez, Jessica; Capellero, Sonia; Cignetto, Simona; Alvaro, Maria; Ciamporcero, Eric; Di Renzo, Maria Flavia; Perera, Timothy; Valabrega, Giorgio; Olivero, Martina
Combination strategy targeting VEGF and HGF/c-met in human renal cell carcinoma models.
2015-01-01 Ciamporcero, E; Miles, Km; Adelaiye, R; Ramakrishnan, S; Shen, L; Ku, S; Pizzimenti, S; Sennino, B; Barrera, G; Pili, R.
Combined Antitumoral Efficacy of the Histone Deacetilase Inhibitor LBH589 and Lipids Peroxidation End Product 4-Hydroxinonenal(HNE)on PC3 Prostate Cancer Cell.
2010-01-01 Pettazzoni P; Pizzimenti S; Toaldo C; Ciamporcero E; Dianzani MU; Sotomayor P; Tagliavacca L; Pil R; Barrera G.
Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer
2018-01-01 Ciamporcero, Eric; Daga, Martina; Pizzimenti, Stefania; Roetto, Antonella; Dianzani, Chiara; Compagnone, Alessandra; Palmieri, Antonietta; Ullio, Chiara; Cangemi, Luigi; Pili, Roberto; Barrera, Giuseppina
Drug Delivery Nanoparticles in Skin Cancers
2014-01-01 Dianzani C; Zara GP; Maina G; Pettazzoni P; Pizzimenti S; Rossi F; Gigliotti CL; Ciamporcero ES; Daga M; Barrera G
Generation of Adducts of 4-Hydroxy-2-nonenal with Heat Shock 60 kDa Protein 1 in Human Promyelocytic HL-60 and Monocytic THP-1 Cell Lines
2015-01-01 Arcaro, Alessia; Daga, Martina; Cetrangolo, Giovanni Paolo; Ciamporcero, Eric Stefano; Lepore, Alessio; Pizzimenti, Stefania; Petrella, Claudia; Graf, Maria; Uchida, Koji; Mamone, Gianfranco; Ferranti, Pasquale; Ames, Paul R J; Palumbo, Giuseppe; Barrera, Giuseppina; Gentile, Fabrizio
GSH-responsive nanoparticles in the treatment of tumor cells.
2015-01-01 Pizzimenti, Stefania; Daga, Martina; Ullio, Chiara; Dianzani, Chiara; Cavalli, Roberta; Trotta, Francesco; Zara, Gian Paolo; Ferretti, Carlo; Gigliotti, Casimiro L.; Ciamporcero, Eric S.; Barrera, Giuseppina .
GSH-targeted nanosponges increase doxorubicin-induced toxicity "in vitro" and "in vivo" in cancer cells with high antioxidant defenses
2016-01-01 Daga, Martina; Ullio, Chiara; Argenziano, Monica; Dianzani, Chiara; Cavalli, Roberta; Trotta, Francesco; Ferretti, Carlo; Zara, Gian Paolo; Gigliotti, Casimiro L.; Ciamporcero, Eric S.; Pettazzoni, Piergiorgio; Corti, Denise; Pizzimenti, Stefania; Barrera, Giuseppina
Hippo pathway effector Yes-associated protein and cisplatin resistance in transitional cell carcinoma of the bladder
2014-01-01 Ciamporcero, Eric Stefano; Shen, He; Chintala, Sreenivasulu; Ramakrishnan, Swathi; Ku, Sheng Y.; Miles, Kiersten M.; Pizzimenti, Stefania; Johnson, Candace; Zhang, Jianmin; Barrera, Giuseppina; Pili, Roberto
Improved Anti-Tumoral Therapeutic Efficacy of 4-Hydroxynonenal Incorporated in Novel Lipid Nanocapsules in 2D and 3D Models
2015-01-01 Pizzimenti, Stefania; Daga, Martina; Ciamporcero, Eric; Toaldo, Cristina; Pettazzoni, Piergiorgio; Osella-Abate, Simona; Novelli, Mauro; Minelli, Rosalba; Bisazza, Agnese; Gamba, Paola; Testa, Gabriella; Ullio, Chiara; Ferruti, Paolo; Ranucci, Elisabetta; Bernengo, Maria Grazia; Ferretti, Carlo; Dianzani, Chiara; Biasi, Fiorella; Barrera, Giuseppina; Cavalli, Roberta
In Vitro Modeling of Tissue-Specific 3D Microenvironments and Possibile Application to Pediatric Cancer Research
2014-01-01 N. Steimberg; G. Mazzoleni; E.S. Ciamporcero; C. Ullio; M. Daga; G. Barrera; S. Pizzimenti
Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cells.
2011-01-01 Pettazzoni P; Pizzimenti S; Toaldo C; Sotomayor P; Tagliavacca L; Liu S; Wang D; Minelli R; Ellis L; Atadja P; Ciamporcero E; Dianzani MU; Barrera G; Pili R.
Interaction of aldehydes derived from lipid peroxidation and membrane proteins.
2013-01-01 Pizzimenti S; Ciamporcero E; Daga M; Pettazzoni P; Arcaro A; Cetrangolo G; Minelli R; Dianzani C; Lepore A; Gentile F; Barrera G.
Lipid peroxidation in colorectal carcinogenesis: bad and good news
2012-01-01 PIZZIMENTI S; TOALDO C; PETTAZZONI P; CIAMPORCERO E; DIANZANI MU; BARRERA G
Nuclear factor erythroid 2-related factor-2 activity controls 4-hydroxynonenal metabolism and activity in prostate cancer cells.
2011-01-01 Pettazzoni P; Ciamporcero E; Medana C; Pizzimenti S; Dal Bello F; Minero VG; Toaldo C; Minelli R; Uchida K; Dianzani MU; Pili R; Barrera G.
PPARy in coronary atherosclerosis: In vivo expression pattern and correlations with hyperlipidemic status and statin treatment
2011-01-01 Pucci, A; Formato, L; Muscio, M; Brscic, E; Pizzimenti, S; Ferroni, F; Ribezzo, M; Toaldo, C; Pettazzoni, P; Ciamporcero, E; Barrera, G; Rinaldi, M; Bergamasco, L; Sheiban, I; Spinnler, Mt
Role of 4-Hydroxynonenal-Protein Adducts in Human Diseases.
2015-01-01 Barrera G;Pizzimenti S;Ciamporcero ES;Daga M;Ullio C;Arcaro A;Cetrangolo GP;Ferretti C;Dianzani C;Lepore A;Gentile F
Rosiglitazone and AS601245 Decrease Cell Adhesion and Migartion Trhougt modulation of specific Gene Expression in Human Colon Cancer Cells.
2012-01-01 R. Minelli;A.Cerbone;C. Toaldo;E. Ciamporcero;S. Pizzimenti; P. Pettazzoni; M. Dianzani; C. Ferretti; C. Dianzani; G. Barrera
Rosiglitazone and AS601245 Decrease Cell Adhesion and Migration through Modulation of Specific Gene Expression in Human Colon Cancer Cells
2012-01-01 Cerbone A; Toaldo C; Minelli R; Ciamporcero E; Pizzimenti S; Pettazzoni P; Roma G; Dianzani MU; Ullio C; Ferretti C; Dianzani C; Barrera G
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| AS601245, an anti-inflammatory JNK inhibitor, and clofibrate have a synergistic effect in inducing cell responses and in affecting the gene expression profile, in CaCo-2 colon cancer cells. | 2012 | Angelo Cerbone; Cristina Toaldo; Stefania Pizzimenti; Piergiorgio Pettazzoni; Chiara Dianzani; Rosalba Minelli; Eric Ciamporcero; Guglielmo Roma; Mario Umberto Dianzani; Roberto Canaparo; Carlo Ferretti; and Giuseppina Barrera | |
| Cancer Cells Haploinsufficient for ATM Are Sensitized to PARP Inhibitors by MET Inhibition | 2022 | D'Ambrosio, Concetta; Erriquez, Jessica; Capellero, Sonia; Cignetto, Simona; Alvaro, Maria; Ciamporcero, Eric; Di Renzo, Maria Flavia; Perera, Timothy; Valabrega, Giorgio; Olivero, Martina | |
| Combination strategy targeting VEGF and HGF/c-met in human renal cell carcinoma models. | 2015 | Ciamporcero, E; Miles, Km; Adelaiye, R; Ramakrishnan, S; Shen, L; Ku, S; Pizzimenti, S; Sennino, B; Barrera, G; Pili, R. | |
| Combined Antitumoral Efficacy of the Histone Deacetilase Inhibitor LBH589 and Lipids Peroxidation End Product 4-Hydroxinonenal(HNE)on PC3 Prostate Cancer Cell. | 2010 | Pettazzoni P; Pizzimenti S; Toaldo C; Ciamporcero E; Dianzani MU; Sotomayor P; Tagliavacca L; Pil R; Barrera G. | |
| Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer | 2018 | Ciamporcero, Eric; Daga, Martina; Pizzimenti, Stefania; Roetto, Antonella; Dianzani, Chiara; Compagnone, Alessandra; Palmieri, Antonietta; Ullio, Chiara; Cangemi, Luigi; Pili, Roberto; Barrera, Giuseppina | |
| Drug Delivery Nanoparticles in Skin Cancers | 2014 | Dianzani C; Zara GP; Maina G; Pettazzoni P; Pizzimenti S; Rossi F; Gigliotti CL; Ciamporcero ES; Daga M; Barrera G | |
| Generation of Adducts of 4-Hydroxy-2-nonenal with Heat Shock 60 kDa Protein 1 in Human Promyelocytic HL-60 and Monocytic THP-1 Cell Lines | 2015 | Arcaro, Alessia; Daga, Martina; Cetrangolo, Giovanni Paolo; Ciamporcero, Eric Stefano; Lepore, Alessio; Pizzimenti, Stefania; Petrella, Claudia; Graf, Maria; Uchida, Koji; Mamone, Gianfranco; Ferranti, Pasquale; Ames, Paul R J; Palumbo, Giuseppe; Barrera, Giuseppina; Gentile, Fabrizio | |
| GSH-responsive nanoparticles in the treatment of tumor cells. | 2015 | Pizzimenti, Stefania; Daga, Martina; Ullio, Chiara; Dianzani, Chiara; Cavalli, Roberta; Trotta, Francesco; Zara, Gian Paolo; Ferretti, Carlo; Gigliotti, Casimiro L.; Ciamporcero, Eric S.; Barrera, Giuseppina . | |
| GSH-targeted nanosponges increase doxorubicin-induced toxicity "in vitro" and "in vivo" in cancer cells with high antioxidant defenses | 2016 | Daga, Martina; Ullio, Chiara; Argenziano, Monica; Dianzani, Chiara; Cavalli, Roberta; Trotta, Francesco; Ferretti, Carlo; Zara, Gian Paolo; Gigliotti, Casimiro L.; Ciamporcero, Eric S.; Pettazzoni, Piergiorgio; Corti, Denise; Pizzimenti, Stefania; Barrera, Giuseppina | |
| Hippo pathway effector Yes-associated protein and cisplatin resistance in transitional cell carcinoma of the bladder | 2014 | Ciamporcero, Eric Stefano; Shen, He; Chintala, Sreenivasulu; Ramakrishnan, Swathi; Ku, Sheng Y.; Miles, Kiersten M.; Pizzimenti, Stefania; Johnson, Candace; Zhang, Jianmin; Barrera, Giuseppina; Pili, Roberto | |
| Improved Anti-Tumoral Therapeutic Efficacy of 4-Hydroxynonenal Incorporated in Novel Lipid Nanocapsules in 2D and 3D Models | 2015 | Pizzimenti, Stefania; Daga, Martina; Ciamporcero, Eric; Toaldo, Cristina; Pettazzoni, Piergiorgio; Osella-Abate, Simona; Novelli, Mauro; Minelli, Rosalba; Bisazza, Agnese; Gamba, Paola; Testa, Gabriella; Ullio, Chiara; Ferruti, Paolo; Ranucci, Elisabetta; Bernengo, Maria Grazia; Ferretti, Carlo; Dianzani, Chiara; Biasi, Fiorella; Barrera, Giuseppina; Cavalli, Roberta | |
| In Vitro Modeling of Tissue-Specific 3D Microenvironments and Possibile Application to Pediatric Cancer Research | 2014 | N. Steimberg; G. Mazzoleni; E.S. Ciamporcero; C. Ullio; M. Daga; G. Barrera; S. Pizzimenti | |
| Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cells. | 2011 | Pettazzoni P; Pizzimenti S; Toaldo C; Sotomayor P; Tagliavacca L; Liu S; Wang D; Minelli R; Ellis L; Atadja P; Ciamporcero E; Dianzani MU; Barrera G; Pili R. | |
| Interaction of aldehydes derived from lipid peroxidation and membrane proteins. | 2013 | Pizzimenti S; Ciamporcero E; Daga M; Pettazzoni P; Arcaro A; Cetrangolo G; Minelli R; Dianzani C; Lepore A; Gentile F; Barrera G. | |
| Lipid peroxidation in colorectal carcinogenesis: bad and good news | 2012 | PIZZIMENTI S; TOALDO C; PETTAZZONI P; CIAMPORCERO E; DIANZANI MU; BARRERA G | |
| Nuclear factor erythroid 2-related factor-2 activity controls 4-hydroxynonenal metabolism and activity in prostate cancer cells. | 2011 | Pettazzoni P; Ciamporcero E; Medana C; Pizzimenti S; Dal Bello F; Minero VG; Toaldo C; Minelli R; Uchida K; Dianzani MU; Pili R; Barrera G. | |
| PPARy in coronary atherosclerosis: In vivo expression pattern and correlations with hyperlipidemic status and statin treatment | 2011 | Pucci, A; Formato, L; Muscio, M; Brscic, E; Pizzimenti, S; Ferroni, F; Ribezzo, M; Toaldo, C; Pettazzoni, P; Ciamporcero, E; Barrera, G; Rinaldi, M; Bergamasco, L; Sheiban, I; Spinnler, Mt | |
| Role of 4-Hydroxynonenal-Protein Adducts in Human Diseases. | 2015 | Barrera G;Pizzimenti S;Ciamporcero ES;Daga M;Ullio C;Arcaro A;Cetrangolo GP;Ferretti C;Dianzani C;Lepore A;Gentile F | |
| Rosiglitazone and AS601245 Decrease Cell Adhesion and Migartion Trhougt modulation of specific Gene Expression in Human Colon Cancer Cells. | 2012 | R. Minelli;A.Cerbone;C. Toaldo;E. Ciamporcero;S. Pizzimenti; P. Pettazzoni; M. Dianzani; C. Ferretti; C. Dianzani; G. Barrera | |
| Rosiglitazone and AS601245 Decrease Cell Adhesion and Migration through Modulation of Specific Gene Expression in Human Colon Cancer Cells | 2012 | Cerbone A; Toaldo C; Minelli R; Ciamporcero E; Pizzimenti S; Pettazzoni P; Roma G; Dianzani MU; Ullio C; Ferretti C; Dianzani C; Barrera G |